Market for Proteomics Research Tools Facing Sharp Growth Trend

A report recently released to the biotech industry predicts sharp growth in research efforts in the field of proteomics with concurrent growth in sales of research supplies and equipment.

The report, “Proteomics Markets for Research and IVD Applications,” which was prepared by Kalorama Information (New York, NY, USA), indicated that the USD 5 billion market for proteomics instruments, reagents, and testing for research and diagnostic applications was likely to grow rapidly over the next several years, despite cost pressures generally in research.

Proteomics is the study of protein structure and function. At the cellular level, investigators attempt to determine which proteins are expressed, when and where they are expressed, what is their structure in both active and inactive states, what roles they play in the life of the cell, and how they interact with other proteins and molecules.

While many different types of technologies are used to study proteins, demands for the three main technologies: mass spectrometry, antibodies (or antibody capture), and knowledge bases are expected to grow significantly.

“It is enormously difficult to study proteins, but hard-fought discoveries made in the research enable biomarker discovery, drug discovery, new IVDs, and personalized solutions,” said Bruce Carlson, publisher of Kalorama Information. “There are many manufacturers willing to assist customers with technologies, creating a vibrant market. New platforms based on a wide range of proteomics technologies have already started to reach the in vitro diagnostics market. The major question today is not whether or not these novel platforms and biomarkers will emerge as a significant market opportunity in the IVD market, but when. How long will it take for companies to obtain the required regulatory approvals? How long will it take for the tests to penetrate these markets? The answers to this question will vary with individual platforms and assays, and will depend on factors such as the unmet need, how well the new platform and assays meet that need, costs, etc.”

Related Links:
Kalorama Information